Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
1.
Mucosal Immunol ; 5(4): 444-54, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22472773

ABSTRACT

Sampling of mucosal antigens regulates immune responses but may also promote dissemination of mucosal pathogens. Lung dendritic cells (LDCs) capture antigens and traffic them to lung-draining lymph nodes (LDLNs) dependent on the chemokine receptor CCR7 (chemokine (C-C motif) receptor 7). LDCs also capture lung pathogens such as Bacillus anthracis (BA). However, we show here that the initial traffic of BA spores from lungs to LDLNs is largely independent of LDCs and CCR7, occurring instead in association with B cells. BA spores rapidly bound B cells in lungs and cultured mouse and human B cells. Binding was independent of the B-cell receptor (BCR). B cells instilled in the lungs trafficked to LDLNs and BA spore traffic to LDLNs was impaired by B-cell deficiency. Depletion of B cells also delayed death of mice receiving a lethal BA infection. These results suggest that mucosal B cells traffic BA, and possibly other antigens, from lungs to LDLNs.


Subject(s)
Anthrax/immunology , B-Lymphocytes/immunology , Bacillus anthracis/immunology , Lung/immunology , Animals , Anthrax/microbiology , Anthrax/mortality , B-Lymphocytes/metabolism , Cell Line , Dendritic Cells/immunology , Dendritic Cells/metabolism , Disease Models, Animal , Immunoglobulin M/immunology , Immunoglobulin M/metabolism , Lung/microbiology , Lymph Nodes/immunology , Lymph Nodes/metabolism , Lymphocyte Depletion , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Receptors, Antigen, B-Cell/immunology , Receptors, Antigen, B-Cell/metabolism , Receptors, CCR7/immunology , Receptors, CCR7/metabolism , Receptors, Complement/immunology , Receptors, Complement/metabolism , Spores, Bacterial/immunology
2.
Biochem Biophys Res Commun ; 288(2): 313-20, 2001 Oct 26.
Article in English | MEDLINE | ID: mdl-11606045

ABSTRACT

Phosphorylation of murine CD120a by p42(mapk/erk2) has been shown to inhibit its ability to initiate apoptosis while preserving signaling events such as NF-kappaB activation. Therefore, we sought to determine if p42(mapk/erk2) was also capable of phosphorylating additional human death receptors within the TNF receptor superfamily. These studies showed that CD120a and DR3 are significantly phosphorylated by p42(mapk/erk2) but Fas, DR4 and DR5 are not. Additionally, we demonstrated that (i) the p42(mapk/erk2)-dependent phosphorylation of CD120a and DR3 occurred on Ser and Thr residues, (ii) p42(mapk/erk2) phosphorylated residues located in the membrane proximal regions but not the death domains of CD120a and DR3, (iii) Ser 253 is a preferred site of phosphorylation on CD120a, and (iv) the p42(mapk/erk2)-dependent phosphorylation of the DR3 cytoplasmic domain occurred exclusively at non-p42/44(mapk/erk2/1) consensus sites. These findings suggest that human death receptors segregate into two groups along lines of phylogeny with respect to Ser/Thr phosphorylation by p42(mapk/erk2).


Subject(s)
Mitogen-Activated Protein Kinase 1/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Animals , Antigens, CD/metabolism , COS Cells , Consensus Sequence , Cytoplasm/metabolism , Humans , Leukocytes, Mononuclear/metabolism , MAP Kinase Kinase 1 , Mitogen-Activated Protein Kinase Kinases/metabolism , Okadaic Acid/pharmacology , Phosphoamino Acids/analysis , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , Protein Structure, Tertiary , Receptors, TNF-Related Apoptosis-Inducing Ligand , Receptors, Tumor Necrosis Factor, Member 25 , Receptors, Tumor Necrosis Factor, Type I , Recombinant Proteins/metabolism , Tetradecanoylphorbol Acetate/pharmacology , fas Receptor/metabolism
3.
Pediatr Pulmonol ; 32(4): 293-302, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11568990

ABSTRACT

Inhaled corticosteroids are commonly used in cystic fibrosis (CF), but there are few studies evaluating their safety in young children. We, therefore, prospectively administered beclomethasone diproprionate (BDP) to 12 clinically stable young children with CF to examine the safety of this therapy with respect to adrenal suppression and airway infection. To determine potential mechanisms of corticosteroid action in CF, we also examined airway markers of inflammation before and after inhaled steroid treatment. BDP 210 microg twice a day was given via spacer for 2 months. Twelve-hour serum and urine cortisols and response to low-dose synthetic ACTH cortisol stimulation were assessed. Bronchoalveolar lavage fluid (BALF) was examined pre- and posttreatment with BDP by quantitative bacteriology and indices of airway inflammation, including levels of total neutrophils, neutrophil elastase-alpha-1 antiprotease complexes (NEAP), CA 19-9 mucin-associated antigen, interleukin-8 (IL-8), and macrophage IL-8 mRNA. Following 2 months of treatment, serum and urine cortisol levels were unchanged. Response to low-dose ACTH cortisol stimulation was not significantly decreased at 30 min. Posttreatment BALF bacterial density was not statistically different from pretreatment; however, one patient who was initially culture negative became culture-positive with Hemophilus influenzae. BALF total neutrophil counts, corrected for epithelial lining fluid dilution, were decreased to approximately one third of pretreatment values (P = 0.03). NEAP and CA 19-9 mucin-associated antigen demonstrated similar decreases. BALF IL-8 levels and macrophage IL-8 mRNA levels were not statistically changed. These findings suggest that treatment with BDP 420 microg per day for 2 months in young children with CF does not affect urine and blood cortisol, causes no decrease in adrenal reserve, and does not result in a clinically significant increase in airway infection. In addition, the fall in bronchoalveolar lavage fluid inflammatory markers following BDP suggests possible modulation of neutrophil influx into the CF airway and provides justification for further studies of inhaled corticosteroids in CF.


Subject(s)
Adrenal Glands/drug effects , Anti-Inflammatory Agents/administration & dosage , Beclomethasone/administration & dosage , Cystic Fibrosis/drug therapy , Inflammation Mediators/analysis , Interleukin-8/analysis , RNA, Messenger/analysis , Administration, Inhalation , Adolescent , Adrenal Glands/physiology , Airway Resistance/drug effects , Analysis of Variance , Bronchoalveolar Lavage Fluid/cytology , Bronchoscopy , Child , Child, Preschool , Cystic Fibrosis/diagnosis , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Follow-Up Studies , Humans , Male , Nebulizers and Vaporizers , Pilot Projects , Probability , Prospective Studies , Statistics, Nonparametric , Treatment Outcome
4.
Am J Respir Cell Mol Biol ; 24(5): 627-32, 2001 May.
Article in English | MEDLINE | ID: mdl-11350834

ABSTRACT

The thiol reducing agent N-acetylcysteine (NAC) is commonly used as an "antioxidant" in studies examining gene expression, signaling pathways, and outcome in acute and chronic models of lung injury. It is less widely appreciated that NAC can also undergo auto-oxidation and behave as an oxidant. We showed previously that NAC can have opposite effects on the activation of nuclear factor-kappaB depending on whether or not serum is present, and that the effects of NAC in the absence of serum are mimicked by various oxidants. Here we show that in a serum-depleted environment (0.1% fetal bovine serum), NAC substantially inhibited lipopolysaccharide (LPS) activation of the mitogen-activated protein kinases (MAPKs), namely extracellular signal-regulated kinase (ERK), p38mapk, and c-Jun NH2-terminal kinase (JNK). By contrast, in the presence of 10% serum, NAC had no effect on LPS activation of p42 and p44 ERK and in fact enhanced LPS induction of p38mapk and JNK phosphorylation. Because serum can significantly alter the redox state, these findings highlight the importance of the local redox milieu in signal transduction.


Subject(s)
Acetylcysteine/pharmacology , Blood Proteins/pharmacology , MAP Kinase Signaling System/drug effects , Macrophages/metabolism , Animals , Cell Line , Electrophoresis, Polyacrylamide Gel , Enzyme Activation/drug effects , Immunoblotting , JNK Mitogen-Activated Protein Kinases , Lipopolysaccharides/pharmacology , Macrophage Activation/drug effects , Macrophage Activation/physiology , Macrophages/cytology , Macrophages/drug effects , Mice , Mitogen-Activated Protein Kinases/metabolism , Oxidation-Reduction/drug effects , Phosphorylation/drug effects , p38 Mitogen-Activated Protein Kinases
5.
Infect Immun ; 69(4): 2001-10, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11254551

ABSTRACT

Nitric oxide (NO*) expression by inducible nitric oxide synthase (iNOS) is an important host defense mechanism against Mycobacterium tuberculosis in mononuclear phagocytes. The objective of this investigation was to examine the role of mitogen-activated protein (MAP) kinase (MAPK) and nuclear factor kappaB (NF-kappaB) signaling pathways in the regulation of iNOS and NO* by a mycobacterial cell wall lipoglycan known as mannose-capped lipoarabinomannan (ManLAM). Specific pharmacologic inhibition of the extracellular-signal-regulated kinase (ERK) or NF-kappaB pathway revealed that both these signaling cascades were required in gamma interferon (IFN-gamma)-ManLAM-induced iNOS protein and NO2- expression in mouse macrophages. Transient cotransfection of dominant-negative protein mutants of the c-Jun NH2-terminal kinase (JNK) pathway revealed that the MAP kinase kinase 7 (MKK7)-JNK cascade also mediated IFN-gamma-ManLAM induction of iNOS promoter activity whereas MKK4 did not. Overexpression of null mutant IkappaBalpha, a potent inhibitor of NF-kappaB activation, confirmed that the IkappaBalpha kinase (IKK)-NF-kappaB signaling pathway enhanced IFN-gamma-ManLAM-induced iNOS promoter activity. By contrast, activated p38mapk inhibited iNOS induction. These results indicate that combined IFN-gamma and ManLAM stimulation induced iNOS and NO. expression and that MEK1-ERK, MKK7-JNK, IKK-NF-kappaB, and p38mapk signaling pathways play important regulatory roles.


Subject(s)
I-kappa B Proteins , Lipopolysaccharides/pharmacology , Mitogen-Activated Protein Kinase Kinases/physiology , Mitogen-Activated Protein Kinases/physiology , Mycobacterium tuberculosis/immunology , NF-kappa B/physiology , Nitric Oxide Synthase/biosynthesis , Nitric Oxide/biosynthesis , Protein Serine-Threonine Kinases/physiology , Animals , Cell Line , DNA-Binding Proteins/physiology , Enzyme Induction , Interferon-gamma/pharmacology , JNK Mitogen-Activated Protein Kinases , MAP Kinase Kinase 1 , MAP Kinase Kinase 7 , Mice , NF-KappaB Inhibitor alpha , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , Promoter Regions, Genetic , p38 Mitogen-Activated Protein Kinases
6.
J Biol Chem ; 276(20): 17252-60, 2001 May 18.
Article in English | MEDLINE | ID: mdl-11278725

ABSTRACT

Ligation of the tumor necrosis factor alpha receptor CD120a initiates responses as diverse as apoptosis and the expression of NF-kappaB-dependent pro-survival genes. How these opposing responses are controlled remains poorly understood. Here we demonstrate that phosphorylation by p42(mapk/erk2) inhibits the apoptotic activity of CD120a while preserving its ability to activate NF-kappaB. Phosphorylated CD120a is re-localized from the Golgi complex to tubular structures of the endoplasmic reticulum wherein it recruits Bcl-2. Antisense-mediated down-regulation of Bcl-2 antagonized the localization of CD120a to tubular structures and reversed the protection from apoptosis conferred by receptor phosphorylation. We propose that phosphorylation of CD120a represents a novel, Bcl-2-dependent mechanism by which the apoptotic activity of the receptor may be regulated. Thus, oncogenic activation of p42(mapk/erk2) may serve to inhibit the apoptotic activity of this death receptor while preserving NF-kappaB-dependent responses and may thus indirectly contribute to a failure to eliminate cells bearing oncogenes of the Ras-Raf-MEK-p42(mapk/erk2) pathway.


Subject(s)
Adaptor Proteins, Signal Transducing , Antigens, CD/metabolism , Apoptosis/physiology , Intracellular Signaling Peptides and Proteins , Mitogen-Activated Protein Kinase 1/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Apoptosis/drug effects , CASP8 and FADD-Like Apoptosis Regulating Protein , Carrier Proteins/metabolism , Caspase 8 , Caspase 9 , Caspases/metabolism , Cell Line , Cell Survival , Fas-Associated Death Domain Protein , Genes, Reporter , Genes, bcl-2 , Golgi Apparatus/metabolism , HeLa Cells , Humans , In Situ Nick-End Labeling , NF-kappa B/metabolism , Phosphorylation , Protein Transport , Proteins/metabolism , Receptors, Tumor Necrosis Factor, Type I , Recombinant Proteins/metabolism , TNF Receptor-Associated Factor 1 , TNF Receptor-Associated Factor 2 , Transfection , Tumor Necrosis Factor-alpha/pharmacology
7.
Am J Physiol Cell Physiol ; 280(3): C441-50, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11171562

ABSTRACT

Nitric oxide (NO.) produced by inducible nitric oxide synthase (iNOS) mediates a number of important physiological and pathophysiological processes. The objective of this investigation was to examine the role of mitogen-activated protein kinases (MAPKs) in the regulation of iNOS and NO. by interferon-gamma (IFN-gamma) + lipopolysaccharide (LPS) in macrophages using specific inhibitors and dominant inhibitory mutant proteins of the MAPK pathways. The signaling pathway utilized by IFN-gamma in iNOS induction is well elucidated. To study signaling pathways that are restricted to the LPS-signaling arm, we used a subclone of the parental RAW 264.7 cell line that is unresponsive to IFN-gamma alone with respect to iNOS induction. In this RAW 264.7gammaNO(-) subclone, IFN-gamma and LPS are nevertheless required for synergistic activation of the iNOS promoter. We found that extracellular signal-regulated kinase (ERK) augmented and p38(mapk) inhibited IFN-gamma + LPS induction of iNOS. Dominant-negative MAPK kinase-4 inhibited iNOS promoter activation by IFN-gamma + LPS, also implicating the c-Jun NH(2)-terminal kinase (JNK) pathway in mediating iNOS induction. Inhibition of the ERK pathway markedly reduced IFN-gamma + LPS-induced tumor necrosis factor-alpha protein expression, providing a possible mechanism by which ERK augments iNOS expression. The inhibitory effect of p38(mapk) appears more complex and may be due to the ability of p38(mapk) to inhibit LPS-induced JNK activation. These results indicate that the MAPKs are important regulators of iNOS-NO. expression by IFN-gamma + LPS.


Subject(s)
Interferon-gamma/pharmacology , Lipopolysaccharides/pharmacology , MAP Kinase Kinase 4 , Macrophages/metabolism , Mitogen-Activated Protein Kinases/physiology , Nitric Oxide Synthase/metabolism , Nuclear Proteins/physiology , Animals , Cell Line , DNA-Binding Proteins , Drug Synergism , Enzyme Induction/physiology , Enzyme Inhibitors/pharmacology , Genes, Dominant , Imidazoles/pharmacology , Interleukin-1/physiology , JNK Mitogen-Activated Protein Kinases , MAP Kinase Kinase 1 , Mice , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinase Kinases/genetics , Mitogen-Activated Protein Kinase Kinases/pharmacology , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , Nitrites/metabolism , Nuclear Proteins/antagonists & inhibitors , Phosphorylation/drug effects , Promoter Regions, Genetic/drug effects , Protein Serine-Threonine Kinases/antagonists & inhibitors , Pyridines/pharmacology , RNA-Binding Proteins , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/metabolism
8.
J Biol Chem ; 275(10): 6996-7003, 2000 Mar 10.
Article in English | MEDLINE | ID: mdl-10702263

ABSTRACT

The interaction of tumor necrosis factor-alpha with its receptor CD120a (p55) initiates downstream signaling cascades that include the activation of the mitogen-activated protein kinase (MAPK), p42(mapk/erk2). The membrane proximal region of CD120a (p55) is Ser-, Thr-, and Pro-rich and contains four mitogen-activated protein kinase consensus phosphorylation sites. In recent work, we showed that CD120a (p55) itself is a target of phosphorylation by p42(mapk/erk2), and after phosphorylation, the receptor is redistributed from the cell surface and Golgi complex to intracellular tubular structures associated with elements of the endoplasmic reticulum. The goal of this study was to define the specific amino acid residues that are phosphorylated. Deletional mutagenesis of the cytoplasmic domain of CD120a (p55) indicated that two sites located between residues 207-254 and 250-300 were phosphorylated predominantly on Thr and Ser residues, respectively. Site-directed mutagenesis of Ser and Thr residues contained within the extracellular signal-regulated kinase (ERK) consensus sequences indicated that the preferred residues were Thr-236 and Ser-270. Primary phosphorylation at these sites appeared to enable subsequent phosphorylation at Ser-240 and Ser-244, although the level of phosphorylation of these latter two sites was less than the preferred sites. Through the use of specific ligation of CD120a (p55) alone and mice deficient in CD120a (p55), CD120b (p75), or both receptors, CD120a (p55) was shown to be necessary and sufficient for the induction of kinase activity. These findings thus suggest that the phosphorylation of Thr-236 and Ser-270 within the membrane proximal region of CD120a (p55) are the preferred sites of phosphorylation by p42(mapk/erk2) and may set in motion phosphorylation at other sites.


Subject(s)
Antigens, CD/metabolism , Mitogen-Activated Protein Kinase 1/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Animals , Mice , Mice, Inbred C3H , Mutagenesis, Site-Directed , Phosphorylation , Protein Serine-Threonine Kinases , Receptors, Tumor Necrosis Factor, Type I , Tumor Necrosis Factor-alpha/pharmacology
9.
J Biol Chem ; 275(2): 793-800, 2000 Jan 14.
Article in English | MEDLINE | ID: mdl-10625609

ABSTRACT

Cross-linking of CD120a (p55), a receptor for tumor necrosis factor alpha (TNFalpha), initiates downstream events, including the activation of protein Ser/Thr kinases. In this report, we have characterized two protein Ser/Thr kinase substrates that are intrinsically associated with CD120a (p55) in mouse macrophages, and we have investigated the mechanism involved in their phosphorylation. pp130 and pp95 were detected by co-immunoprecipitation with CD120a (p55) from lysates of mouse bone marrow-derived macrophages and were phosphorylated on Ser and Thr residues during in vitro kinase assays in the presence of [gamma-(32)P]ATP. The level of phosphorylation of pp130 and pp95 was rapidly and transiently increased in response to TNFalpha in [(32)P]orthophosphate-labeled macrophages, although the level of pp130 protein associated with CD120a (p55) remained unchanged as detected by [(35)S]methionine labeling. In contrast, pp130 and pp95 were efficiently phosphorylated in in vitro kinase assays of CD120a (p55) immunoprecipitates from unstimulated cells, and the level of phosphorylation was rapidly and transiently reduced in response to TNFalpha. Both pp130 and pp95 were sensitive to dephosphorylation with purified protein phosphatase 2A, and okadaic acid, a PP1/PP2A inhibitor, mimicked the ability of TNFalpha to stimulate the phosphorylation of pp130 and pp95 in intact (32)P-labeled macrophages. Collectively, these findings suggest that pp130 and pp95 are constitutively associated with CD120a (p55) and become inducibly phosphorylated in macrophages in response to TNFalpha. We propose that the underlying mechanism of their phosphorylation may involve the inactivation of a cytoplasmic pp130/pp95 Ser/Thr phosphatase.


Subject(s)
Antigens, CD/metabolism , Macrophages/immunology , Receptors, Tumor Necrosis Factor/metabolism , Alkaline Phosphatase/metabolism , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/immunology , Cells, Cultured , Macrophages/cytology , Mice , Mice, Inbred C3H , Molecular Weight , Okadaic Acid/pharmacology , Peptide Mapping , Phosphopeptides/chemistry , Phosphoprotein Phosphatases/metabolism , Phosphorylation , Protein Phosphatase 2 , Receptors, Tumor Necrosis Factor, Type I , Substrate Specificity , Tumor Necrosis Factor-alpha/metabolism
10.
J Biol Chem ; 274(46): 32975-87, 1999 Nov 12.
Article in English | MEDLINE | ID: mdl-10551865

ABSTRACT

The interaction of tumor necrosis factor-alpha (TNFalpha) with its receptor sets in motion downstream signaling events including the activation of members of the mitogen-activated protein kinase (MAPK) family. In this study, we show that p42(mapk/erk2) phosphorylates sequences present within the cytoplasmic domain of CD120a (p55). By using a GST-CD120a-(207-425) fusion protein as substrate, phosphorylation was induced following stimulation of mouse macrophages with TNFalpha, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and zymosan particles and was blocked by immunodepletion of p42(mapk/erk2) and by specific inhibition of p42(mapk/erk2) activation with PD098059. Transfection of COS-7 cells with CD120a (p55), wild-type p42(mapk/erk2), and constitutively active MEK-1 followed by metabolic labeling with [(32)P]orthophosphate indicated that p42(mapk/erk2) phosphorylated the cytoplasmic domain of CD120a (p55) in intact cells. As a consequence of phosphorylation, CD120a (p55) expression at the plasma membrane and Golgi apparatus was lost and the receptor accumulated in intracellular tubular structures associated with the endoplasmic reticulum. Mutation of the four Ser and Thr ERK consensus phosphorylation sites to Ala residues inhibited the ability of the receptor to redistribute to intracellular tubules in a p42(mapk/erk2)-dependent fashion; whereas mutation of the phosphorylation sites to Asp and Glu residues mimicked the effect of receptor phosphorylation. These findings thus indicate that the phosphorylation of CD120a (p55) alters the subcellular localization of the receptor and may thereby result in changes in its signaling properties.


Subject(s)
Antigens, CD/metabolism , Mitogen-Activated Protein Kinase 1/metabolism , Protein Serine-Threonine Kinases , Receptors, Tumor Necrosis Factor/metabolism , Animals , Antibodies, Monoclonal/pharmacology , Antigens, CD/genetics , Cell Line , Endoplasmic Reticulum/metabolism , Enzyme Inhibitors/pharmacology , HeLa Cells , Humans , MAP Kinase Kinase 1 , Macrophages/metabolism , Mice , Mice, Inbred C3H , Microscopy, Electron , Microscopy, Fluorescence , Mitogen-Activated Protein Kinase Kinases/metabolism , Mutation , Phosphorylation , Protein Binding , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor, Type I , Recombinant Fusion Proteins/metabolism
12.
Biochem Biophys Res Commun ; 258(1): 162-7, 1999 Apr 29.
Article in English | MEDLINE | ID: mdl-10222253

ABSTRACT

Annexin IV was cloned and sequenced from a mouse bone marrow-derived macrophage cDNA library, and was found to exist as three different alternatively spliced transcripts. One transcript contained an additional 688 base pairs inserted within the coding region of the gene including an in-frame stop codon. Translation of this transcript in vitro confirmed the premature arrest of translation which resulted in a truncated annexin IV protein of approximately 22 kDa. Like other members of the annexin family, the product of the wild-type annexin IV transcript bound in a calcium-dependent manner to both phenyl-sepharose and phospholipid vesicles. In contrast, the truncated annexin IV product bound to these substrates in a Ca2+-independent fashion. The existence of a novel form of annexin IV in mouse macrophages may aid in further defining the role of members of the annexin family.


Subject(s)
Annexin A4/genetics , Macrophages/metabolism , Amino Acid Sequence , Animals , Annexin A4/metabolism , Base Sequence , Bone Marrow Cells/metabolism , Calcium/metabolism , Cloning, Molecular , DNA, Complementary , Mice , Molecular Sequence Data , Phospholipids/metabolism , Protein Binding , Sepharose/analogs & derivatives , Sepharose/metabolism , Sequence Homology, Amino Acid
13.
J Immunol ; 162(1): 415-22, 1999 Jan 01.
Article in English | MEDLINE | ID: mdl-9886415

ABSTRACT

The expression of inducible nitric oxide synthase (iNOS) by macrophages is stimulated by coexposure to IFN-gamma and a number of stimuli, including TNF-alpha. Recent work has shown that TNF-alpha activates members of the mitogen-activated protein kinase family that subsequently trans-activate transcription factors implicated in the regulation of iNOS expression. The objective of this study was to systematically evaluate the role of: 1) p42mapk/erk2, 2) p46 c-Jun NH2-terminal kinase/stress-activated protein kinase (p46 JNK/SAPK), and 3) p38mapk in the induction of iNOS expression during costimulation of mouse macrophages with IFN-gamma and TNF-alpha. All three kinases were activated during costimulation with IFN-gamma and TNF-alpha. However, specific antagonism of the p42mapk/erk2 and p38mapk with PD98059 and SKF86002, respectively, had no effect on the induction of iNOS expression. In contrast, blockade of all three kinases with N-acetylcysteine completely blocked the induction of iNOS expression. In addition, specific antagonism of the JNK/SAPK upstream kinases MEKK (mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase) and MKK4 (mitogen-activated protein kinase kinase 4) with dominant inhibitory mutants blocked transcriptional activation of the iNOS promoter in response to costimulation with IFN-gamma and TNF-alpha. Collectively, these findings support the involvement of p46 JNK/SAPK and its upstream kinases in regulating the induction of iNOS following ligation of the TNF-alpha receptor CD120a (p55) in the presence of IFN-gamma.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/physiology , Interferon-gamma/physiology , MAP Kinase Kinase 4 , MAP Kinase Kinase Kinase 1 , Macrophages/enzymology , Mitogen-Activated Protein Kinase Kinases , Mitogen-Activated Protein Kinases , Nitric Oxide Synthase/biosynthesis , Tumor Necrosis Factor-alpha/physiology , 3T3 Cells , Animals , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Enzyme Activation/immunology , Enzyme Induction , Gene Expression Regulation/immunology , JNK Mitogen-Activated Protein Kinases , Mice , Mice, Inbred C3H , Mitogen-Activated Protein Kinase 1/antagonists & inhibitors , Mitogen-Activated Protein Kinase 1/metabolism , Mutation , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , Promoter Regions, Genetic/immunology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases
14.
Am J Respir Crit Care Med ; 158(5 Pt 1): 1626-35, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9817718

ABSTRACT

Insulin-like growth factor-I (IGF-I) has been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF) through its ability to stimulate fibroblast proliferation and collagen synthesis. However, although alveolar macrophages (AM) have been shown to express this growth factor, it is likely to also have other cellular sources. We sought to determine the distribution of cells expressing IGF-I in lung tissues obtained from 10 patients with IPF and 10 control subjects. We evaluated the levels of IGF-I and of a macrophage/monocyte-specific marker, CD68, by immunocytochemistry and quantified by morphometry. In control subjects, IGF-I was localized principally to AM. In contrast, in IPF patients IGF-I was localized to AM, interstitial macrophages, alveolar epithelial cells, and ciliated columnar epithelial cells. The normalized volume density (Vv) of IGF-I-positive (IGF-I+) interstitial macrophages (Vv of IGF-I+ interstitial macrophages/Vv of lung x 100) was increased in patients with IPF as compared with control subjects, and the ratio of Vv of IGF-I+ to CD68(+) interstitial macrophages correlated with: (1) the degree of clinical impairment in patients with IPF as measured by their clinical-radiologic-physiologic (CRP) score; and (2) the degree of collagen deposition in the interstitium. These findings support a role for interstitial macrophages as a source of IGF-I in IPF.


Subject(s)
Insulin-Like Growth Factor I/analysis , Lung/pathology , Pulmonary Fibrosis/pathology , Adult , Antigens, CD/analysis , Antigens, Differentiation, Myelomonocytic/analysis , Cell Division , Cilia/pathology , Collagen/biosynthesis , Epithelial Cells/pathology , Female , Fibroblasts/pathology , Humans , Immunohistochemistry , Insulin-Like Growth Factor I/physiology , Macrophages, Alveolar/pathology , Male , Middle Aged , Monocytes/pathology , Pulmonary Alveoli/pathology
15.
J Biol Chem ; 273(35): 22800-6, 1998 Aug 28.
Article in English | MEDLINE | ID: mdl-9712914

ABSTRACT

Tumor necrosis factor-alpha (TNFalpha) is recognized by the cell-surface receptors CD120a (p55) and CD120b (p75). In the present study, we have investigated the role of these receptors in the expression of NO2-, a stable metabolite of nitric oxide, and inducible nitric oxide synthase (iNOS) by mouse macrophages. Specific antibody-mediated aggregation of CD120a (p55) induced NO2- accumulation in culture supernatants and iNOS mRNA expression in macrophage lysates, whereas cross-linking of CD120b (p75) had a minimal effect. In contrast, simultaneous cross-linking of both receptors led to a marked augmentation in NO2- and iNOS mRNA expression. Antibody-mediated blockade of CD120a (p55) completely inhibited NO2- expression in response to TNFalpha, whereas blockade of CD120b (p75) reduced NO2- accumulation by approximately 50%. Specific ligation of CD120a (p55) with either (i) human TNFalpha or (ii) by incubation with mouse TNFalpha following pretreatment of macrophages with blocking concentrations of anti-CD120b (p75) antibody resulted in a similar reduction in NO2- production in response to TNFalpha. Quantification of iNOS mRNA, protein, and NO2- expression during independent and co-ligation of CD120a (p55) and CD120b (p75) indicated that iNOS mRNA and protein expression was transient in nature when CD120a (p55) was cross-linked alone but was prolonged when both receptors were simultaneously cross-linked. In addition, cross-linking both receptors also led to a potentiation of NO2- accumulation in culture supernatants that was more pronounced at later time points. These findings suggest that while cross-linking of CD120a (p55) is necessary and sufficient for iNOS mRNA and NO2- expression, CD120b (p75) participates by (i) increasing the sensitivity of the cells to TNFalpha, probably by "passing" ligand to CD120a (p55), and (ii) initiating a signaling event that results in a more sustained induction of iNOS mRNA and protein and thereby augments the production of nitric oxide.


Subject(s)
Antigens, CD/physiology , Macrophages/metabolism , Nitric Oxide Synthase/genetics , Nitric Oxide/metabolism , Receptors, Tumor Necrosis Factor/physiology , Signal Transduction/physiology , Animals , Antibodies/pharmacology , Antigens, CD/chemistry , Humans , Interferon-gamma/pharmacology , Macrophages/enzymology , Mice , Mice, Inbred C3H , Nitric Oxide Synthase Type II , Receptors, Tumor Necrosis Factor/agonists , Receptors, Tumor Necrosis Factor/antagonists & inhibitors , Receptors, Tumor Necrosis Factor/chemistry , Receptors, Tumor Necrosis Factor, Type I , Receptors, Tumor Necrosis Factor, Type II , Tumor Necrosis Factor-alpha/pharmacology
16.
Pathobiology ; 66(1): 24-32, 1998.
Article in English | MEDLINE | ID: mdl-9577963

ABSTRACT

The production of cytokine-induced neutrophil chemoattractant (CINC) by functionally diverse mouse bone-marrow-derived macrophages was determined. Studies showed that beta1,3-glucan, IL-beta, TNFalpha and IFNgamma/TNFalpha induced expression and production of CINC in macrophages while neither IFNgamma nor TGFbeta alone induced detectable CINC expression. Pretreatment or simultaneous treatment of macrophages with TGFbeta resulted in suppression of CINC protein production. These studies demonstrate that IFNgamma and TNFalpha, found early during the inflammatory response, induce production of CINC, as well as induce macrophages into a cytocidal state that are capable of killing transformed cells, parasites and bacteria, and recruiting neutrophils. In contrast, TGFbeta, found during reparative stages of the inflammatory response, suppressed production of CINC, while inducing the development of inflammatory macrophages that are capable of producing lysosomal enzymes, enhanced endocytosis and ingestion of particulate matter and function to scavenge debris, debride tissue and stimulate repair.


Subject(s)
Chemokines, CXC , Chemokines/metabolism , Chemotactic Factors/metabolism , Growth Substances/metabolism , Intercellular Signaling Peptides and Proteins , Macrophages/immunology , Animals , Blotting, Northern , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Chemokine CXCL1 , Enzyme-Linked Immunosorbent Assay , Glucan Endo-1,3-beta-D-Glucosidase/pharmacology , Interferon-gamma/pharmacology , Interferons/pharmacology , Macrophages/drug effects , Macrophages/metabolism , Male , Mice , Mice, Inbred C3H , RNA, Messenger/metabolism , Tumor Necrosis Factor-alpha/pharmacology
17.
Biochem Biophys Res Commun ; 253(3): 790-6, 1998 Dec 30.
Article in English | MEDLINE | ID: mdl-9918806

ABSTRACT

Nitric oxide production by macrophages is principally regulated by the calcium-independent enzyme, inducible nitric oxide synthase (iNOS). Both lipopolysaccharide and TNF-alpha synergize with IFN-gamma in the expression of iNOS with subsequent production of nitric oxide. Previous work has shown that IL-4 downregulates iNOS and nitric oxide expression by macrophages stimulated with LPS and IFN-gamma. In this study, we found that IL-4 also downregulated iNOS and nitric oxide expression induced by IFN-gamma and TNF-alpha and in mouse macrophages. Because various members of the mitogen-activated protein kinases and their upstream kinases have been shown to directly or indirectly activate a number of transcription factors including AP-1 and NFkappaB, we examined the effects of IL-4 on TNF-alpha activation of the MAPKs. Our results show that IL-4 modestly inhibited JNK/SAPK and ERK activation by TNF-alpha. Previously, we showed that selective pharmacologic inhibition of the ERK and/or p38mapk pathway did not affect NO2- expression. Treatment of cells with the chloride channel blocker 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) showed a dose-response inhibition of NO2- expression. NPPB was also found to inhibit ERK and JNK/SAPK activation but not p38mapk with TNF-alpha stimulation. The discordance between the marked degree of inhibition of iNOS transcript by IL-4 and the modest inhibition of JNK/SAPK and ERK suggests that the mechanism by which IL-4 inhibits iNOS transcription appears more complex than a mere inhibition of these MAPKs.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Macrophages/metabolism , Nitric Oxide Synthase/biosynthesis , Tumor Necrosis Factor-alpha/pharmacology , Animals , Bone Marrow Cells/metabolism , Drug Interactions , Enzyme Induction , Interferon-gamma/pharmacology , Interleukin-4/pharmacology , JNK Mitogen-Activated Protein Kinases , Macrophages/cytology , Mice , Mice, Inbred C3H , Mitogen-Activated Protein Kinases/metabolism , Nitric Oxide/biosynthesis , Nitric Oxide Synthase Type II , Nitrites/metabolism , Nitrobenzoates/pharmacology , p38 Mitogen-Activated Protein Kinases
18.
Proc Natl Acad Sci U S A ; 94(24): 13169-74, 1997 Nov 25.
Article in English | MEDLINE | ID: mdl-9371818

ABSTRACT

A pleiotropic cytokine, tumor necrosis factor-alpha (TNF alpha), regulates the expression of multiple macrophage gene products and thus contributes a key role in host defense. In this study, we have investigated the specificity and mechanism of activation of members of the c-Jun-NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) subfamily of mitogen-activated protein kinases (MAPKs) in mouse macrophages in response to stimulation with TNF alpha. Exposure of macrophages to TNF alpha stimulated a preferential increase in catalytic activity of the p46 JNK/SAPK isoform compared with the p54 JNK/SAPK isoform as determined by: (i) separation of p46 and p54 JNK/SAPKs by anion exchange liquid chromatography and (ii) selective immunodepletion of the p46 JNK/SAPK from macrophage lysates. To investigate the level of regulation of p46 JNK/SAPK activation, we determined the ability of MKK4/SEK1/JNKK, an upstream regulator of JNK/SAPKs, to phosphorylate recombinant kinase-inactive p46 and p54 JNK/SAPKs. Endogenous MKK4 was able to transphosphorylate both isoforms. In addition, both the p46 and p54 JNK/SAPK isoforms were phosphorylated on their TPY motif in response to TNF alpha stimulation as reflected by immunoblotting with a phospho-specific antibody that recognizes both kinases. Collectively, these results suggest that the level of control of p46 JNK/SAPK activation is distal not only to MKK4 but also to the p54 JNK/SAPK. Preferential isoform activation within the JNK/SAPK subfamily of MAPKs may be an important mechanism through which TNF alpha regulates macrophage phenotypic heterogeneity and differentiation.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Macrophages/drug effects , Mitogen-Activated Protein Kinases , Tumor Necrosis Factor-alpha/pharmacology , Animals , Catalysis , Cells, Cultured , Chromatography, Ion Exchange , Enzyme Activation , JNK Mitogen-Activated Protein Kinases , Macrophages/enzymology , Mice , Phosphorylation
19.
Am J Physiol ; 273(3 Pt 1): L676-83, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9316504

ABSTRACT

Idiopathic pulmonary fibrosis (IPF) and bronchiolitis obliterans with organizing pneumonia (BOOP) are interstitial lung diseases of unknown pathogenesis. Alveolar macrophages play a major role in the regulation of the inflammatory response in these diseases through their ability to produce cytokines that modify the inflammatory response. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) exhibit proinflammatory and anti-inflammatory actions, respectively, and thus an imbalance in the expression of these cytokines may contribute to the pathogenesis of IPF and BOOP. Therefore, we quantified IL-10 and TNF-alpha mRNA levels in alveolar macrophages obtained by bronchoalveolar lavage (BAL) from patients with IPF and BOOP and in normal healthy volunteers. The level of TNF-alpha mRNA in macrophages obtained from IPF and BOOP patients was not significantly different from normal healthy subjects. However, macrophages from patients with IPF and BOOP expressed increased levels of IL-10 mRNA compared with healthy controls. In addition, stimulation of alveolar macrophages with lipopolysaccharide in the presence of a neutralizing anti-IL-10 antibody augmented the production of TNF-alpha over that seen in the absence of anti-IL-10 antibody, suggesting that the increased expression of IL-10 by alveolar macrophages may act to control the expression of TNF-alpha. Paradoxically, measurement of IL-10 protein in cell-free BAL fluid revealed lower amounts of the protein in patients with IPF and BOOP compared with healthy controls.


Subject(s)
Cryptogenic Organizing Pneumonia/immunology , Interleukin-10/biosynthesis , Macrophages, Alveolar/immunology , Pulmonary Fibrosis/immunology , Transcription, Genetic , Tumor Necrosis Factor-alpha/biosynthesis , Adult , Base Sequence , Bronchoalveolar Lavage , Bronchoalveolar Lavage Fluid/cytology , Cryptogenic Organizing Pneumonia/pathology , DNA Probes , Eosinophils/pathology , Female , Humans , Interleukin-10/analysis , Lymphocytes/pathology , Macrophages, Alveolar/pathology , Male , Middle Aged , Molecular Sequence Data , Neutrophils/pathology , Polymerase Chain Reaction , Pulmonary Fibrosis/pathology , RNA, Messenger/biosynthesis , Reference Values , Regression Analysis
20.
J Immunol ; 159(9): 4491-7, 1997 Nov 01.
Article in English | MEDLINE | ID: mdl-9379049

ABSTRACT

TNF-alpha regulates the expression of many proinflammatory and profibrogenic gene products in macrophages, and hence plays a vital role in controlling the inflammatory response. We have shown previously that exposure of macrophages to TNF-alpha stimulates the activation of members of the mitogen-activated protein kinase (MAPK) family. In this study, we have investigated the mechanism of activation of the p38mapk by TNF-alpha in mouse bone marrow-derived macrophages. Exposure to TNF-alpha resulted in the activation of p38mapk, as measured by 1) the trans-phosphorylation of recombinant activating transcription factor-2 substrate by immunoprecipitated p38mapk and 2) specific tyrosine phosphorylation of immunoprecipitated p38mapk. In addition, selective ligation of the TNF-alpha receptor CD120a (p55) with human TNF-alpha was sufficient to induce p38mapk activation. Using an in vitro kinase assay with recombinant kinase-inactive p38mapk as substrate in the presence of [gamma-32P]ATP, the upstream kinases MKK3 (mitogen-activated protein kinase kinase 3) and MKK4 were found to be activated in response to TNF-alpha. These findings suggest that TNF-alpha transiently phosphorylates and activates the three members of the MAPK family, namely p42(mapk/erk2), p46 c-Jun amino-terminal kinase/stress-activated protein kinase (JNK/SAPK), and p38mapk following cross-linking of CD120a (p55), and that MKK3 and MKK4 are capable of phosphorylating p38mapk.


Subject(s)
Bone Marrow Cells/immunology , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , MAP Kinase Kinase 4 , Macrophage Activation/drug effects , Macrophages/immunology , Mitogen-Activated Protein Kinase Kinases , Mitogen-Activated Protein Kinases , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Animals , Bone Marrow Cells/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/immunology , Cells, Cultured , Humans , MAP Kinase Kinase 3 , Mice , Mice, Inbred C3H , Protein Serine-Threonine Kinases/immunology , Protein-Tyrosine Kinases/immunology , Signal Transduction/immunology , p38 Mitogen-Activated Protein Kinases
SELECTION OF CITATIONS
SEARCH DETAIL
...